Vax Before Cancer

 → October 20th, 2020

Eliminating fake vaccine news with pharmacist, nurse, and physician review.

Cancer Vaccine Breaking News

Oct 17 • 2:07 pm CDT

Ontario Students Encouraged to Get Their HPV Vaccination

An Ontario Medical Association (OMA) podcast published on October 15, 2020, is emphasizing the importance of Ontario adolescents getting the human papillomavirus (HPV) vaccine either through their schools or public health units, reported Len Gillis, local journalism initiative reporter.

The OMA podcast featured a conversation with Dr. Amanda Selk, an OB/GYN who practices at Women’s College Hospital, Mount Sinai Hospital, and the Toronto General Hospital, in Canada.

Oct 16 • 7:59 am CDT

Personalized Cancer Vaccine Plus Medication Combo Found Effective

The study results from a Phase Ib clinical trial published in the journal Cell on October 15, 2020, indicate the safety and preliminary efficacy of combined treatment with the personalized, neoantigen-based vaccine NEO-PV-01, and the anti-PD-1 checkpoint inhibitor nivolumab (Opdivo), for patients with advanced melanoma, non-small cell lung cancer, or bladder cancer.

These data support the safety and immunogenicity of this regimen in patients with advanced solid tumors.

Neoantigens arise from mutations in cancer cells and are important targets of T cell-mediated anti-tumor immunity. 

Oct 15 • 10:42 am CDT

U.S. FDA Approves Refractory Classical Hodgkin Lymphoma Therapy

New Jersey-based Merck announced that the U.S. Food and Drug Administration (FDA) has approved an expanded label for KEYTRUDA, Merck’s anti-PD-1 therapy, as monotherapy for the treatment of adult patients with relapsed or refractory classical Hodgkin lymphoma (cHL).

The approval is based on results from the Phase 3 KEYNOTE-204 trial in which KEYTRUDA significantly reduced the risk of disease progression or death by 35% (HR=0.65 [95% CI, 0.48-0.88; p<0.0027]) compared to brentuximab vedotin (BV).

Additionally, median progression-free survival (PFS) was 13.2 months (95% CI, 10.9-19.4) for patients treated with KEYTRUDA and 8.3 months (95% CI, 5.7-8.8) for patients treated with BV.

The FDA also approved an updated pediatric indication for KEYTRUDA for the treatment of pediatric patients with refractory cHL, or cHL that has relapsed after two or more lines of therapy.

Oct 14 • 8:31 pm CDT

Statins Decrease Cancer Risk Separately From Cholesterol

A new study published by eLife on October 13, 2020, found cholesterol-lowering drugs called statins may reduce cancer risk in humans through a pathway unrelated to cholesterol. These results predict that statins reduce cancer risk but other lipid-lowering treatments do not.

'Our work highlights that the effectiveness of statins must be urgently evaluated by large clinical trials for potential use in cancer prevention,' stated senior author Stephen Burgess, Group Leader at the Medical Research Council Biostatistics Unit, part of the University of Cambridge. 

Oct 14 • 6:13 pm CDT

Early-Stage Vaccine Candidate Shows Positive Action in Lung Cancer Study

California based Lineage Cell Therapeutics, Inc. and Cancer Research UK announced on October 13, 2020, encouraging preliminary results from an ongoing Phase 1 clinical study of VAC2 in non-small cell lung cancer (NSCLC).

VAC2 demonstrated remarkably potent induction of immune responses in all patients dosed to date, with high levels of peripheral antigen-specific immunogenicity observed at multiple time points and confirmed by multimer staining.

On the basis of these findings, and following completion of the ongoing VAC2 clinical study in NSCLC, Lineage will seek to evaluate VAC2 in combination with therapies considered biologically complementary to VAC2, such as chemotherapy and the immune cell protectant properties offered by anti-PD1 immunotherapy.

red blood cells Therapeutic Blood Cancer Vaccine Candidate Identified Acute myeloid leukemia vaccine candidate utilizes self-healing polylactic acid microcapsules
  • Cancer
three young women string at the ocean Immune Therapy Shows Promise in Advanced Cervical Cancer Studies Balstilimab and zalifrelimab may present meaningful new therapies for patients with cervical cancer
  • Cancer
  • Cervical Cancer
young girl on ferry boat HPV Vaccination Substantially Protects Women From Cancer Young women benefit from HPV vaccination
  • Cancer
  • Cervical Cancer
  • HPV
  • HPV Cancers
  • Sexually Transmitted Diseases
man playing a guitar Older Cancer Patients At Risk For COVID-19 Age, not cancer increases COVID-19 fatality risk
young bhutan woman HPV Vaccination Significantly Reduced HPV Rates in Women HPV vaccines protect women from various human papillomavirus types
young girls celebrating HPV Vaccination Rates Increased in Most States HPV cancers can be prevented with FDA approved vaccines
blood tests Blood Test Reveals Cancer 4-Years Sooner PanSeer test detected stomach, esophageal, colorectal, lung, and liver cancer
men running up a rocky hill New Test Identifies Prostate Cancer Patients With BRCA Mutations Cancer liquid biopsy is a blood plasma test that is less invasive than a tissue biopsy for assessing germline or somatic BRCA mutations
mexican folk dancing Gallbladder Cancer Vaccine Genomic Analysis Completed Mutated ELF3 identified as potential gallbladder cancer vaccine candidate
depiction of cancer cells Blood Cancer Vaccine Candidate Is Comprised of Antibodies Fused with Tumor-Specific Protein University of Queensland cancer vaccine candidate CLEC9A‐WT1 identified as promising immunotherapy for malignancies
cancer cells New Insights Will Reduce Cancer’s Walk-About Oleic acid coating from lymph nodes enable cancer cells to safely enter the blood, travel to other locations, and form metastatic tumors
people hanging out at barton springs in austin Personalized Cancer Vaccine Demonstrates Long-Term Survival Benefit Among High-Risk Melanoma Patients Elios Therapeutics TLPLDC vaccine is a personalized treatment that is created using a person's blood and tumor cells
scientist DNA Medicine Receives FDA Support For Recurrent Respiratory Papillomatosis FDA orphan drug designation granted for Inovio INO-3107 treatment
young women laying on a bed talking New Cancer Screening Guideline Calls For Less and More Simplification HPV vaccination has led to a drop in rates of precancerous cervical changes
mom feeding baby Breast Cancer Vaccine Technology Readies For Human Study Cleveland Clinic and Anixa Biosciences technology takes advantage of self-proteins to stop cancer
depiciton of white blood cells Cell-Based Gene Therapy Approved by the FDA for the Treatment of MCL
teens having fun with color paints ‘Parental Hesitancy to Protect Children Against HPV is Troubling’
young boy looking at the ocean surf Prostate Cancer’s Casual Relationship With HPV
facebook page Facebook’s Vaccine Fake-News Focuses on HPV
women standing in front of a huge clock Cancer Society Disputes HPV Vaccination Guideline Update
women in a meeting Cervical Cancer Co-Testing is Best
young girls lying on a car chatting El Paso Shares Strategies to Increase HPV Vaccinations
two friend happy and smiling FDA Approves At-Home Breast Cancer Treatment
sunny day on the beach protected by the sun Melanoma Vaccine Granted Fast-Track Designation
copehnhagen square people Vaccines Almost Eliminated HPV 16 & 18
gym class circa 1940s ‘Sit Less and Move More’ To Reduce Cancer Risk
electric pulse in cells $38.1 Million Funding Will Accelerate mRNA Cancer Therapeutic Programs
scientific lab Cell-Based Cancer Vaccine Consortium Formed
group of teens sitting in a circle outside How To Improve HPV Vaccination Rates For Everyone
group of people sitting around a camp fire HPV Vaccine Approved for Head, Neck and Throat Cancer Prevention
honduran women in traditional garb hrHPV Prevalence Rates Differ by Country
african woman silhouette HPV Vaccines Becoming More Available
children looking thru a balcony Quantifying Pediatric Cancer Risk During Coronavirus Pandemic
depicition of cancer cells AI-Based Neoantigen Prediction Model Found Very Accurate
cancer word in a newspaper highlighted 50 Cancer Types Accurately Detected

For more articles, try our search.